The purpose of this study is to monitor the performance of the Summit™ hip in the treatment of patients with hip joint disease requiring a total hip replacement. Patients who enter the study will be evaluated at regular intervals following hip surgery using patient, clinical and x-ray assessments.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
275
A cementless, tapered femoral component for use in total hip replacement
2. Ruijin Hospital
Shanghai, China
3. The University of Hong Kong at Queen Mary Hospital
Pokfulam, Hong Kong
1. Ospedale Riuniti Di Bergamo
Bergamo, Italy
5. Middlemore Hospital
Auckland, New Zealand
4. Yonsei University College of Medicine
Seoul, South Korea
Kaplan-Meier survivorship calculated at the five-year time point
Time frame: 5yrs post-surgery
Kaplan-Meier survivorship calculations
Time frame: Annually
Harris Hip score
Time frame: 6mths, 1yr, 2yrs, 3yrs, 5yrs, 7yrs, 10yrs and 15yrs post-surgery
Oxford score
Time frame: 6mths and Annually post-surgery
UCLA activity rating
Time frame: 6mths and Annually post-surgery
Thigh pain analysis
Time frame: 6mths and Annually post-surgery
Radiological analysis
Time frame: pre-discharge, 6mths, 1yr, 2yrs, 3yrs, 5yrs, 7yrs, 10yrs and 15yrs post-surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.